breast cancer and glp 1 drugs GLP-1 Receptor Agonists in Cancer: A New Frontier in Obesity Prognosis Management GLP-1 Drugs and Breast Cancer:

(These drugs are also known as Ozempic and Mounjaro when people take the same medications for diabetes.) And the amount of weight people lost with retatrutide matches or exceeds the amount of weight people lose when they have bariatric weight-loss surgery

Clinical trials showed average weight loss of 5-8% of body weight with liraglutide 3.0mg daily, roughly half of what semaglutide or tirzepatide achieves

The Lancet , 397 (10286), 1736-1748

Clin Drug Investig

It slows gastric emptying (leading to early satiety), increases insulin secretion, and signals the brain to reduce appetite

2.3.3 GLP-1, inflammation and the gut microbiome In view of the above, increasing evidence indicates a complex and reciprocal relationship among glucagon-like peptide-1 (GLP-1), gut microbiota, and inflammation